Efficacy and safety of the mosquitocidal drug ivermectin to prevent malaria transmission after treatment: a double-blind, randomized, clinical trial. (2015)
Attributed to:
MRC Centre for Outbreak Analysis and Modelling Renewal
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1093/cid/ciu797
PubMed Identifier: 25414262
Publication URI: http://europepmc.org/abstract/MED/25414262
Type: Journal Article/Review
Volume: 60
Parent Publication: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
Issue: 3
ISSN: 1058-4838